6L60.F Senseonics Holdings Inc.

Healthcare Medical Devices Frankfurt Exchange
8.85 EUR
Close of Nov 11, 2026
4.04 9.55
Market cap
EUR 468M
P/E
-
P/B
4.93x
ROE
-174.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 6L60.F undervalued?

Graham number

The Graham number of Senseonics Holdings Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Senseonics Holdings Inc. fundamental analysis

No fundamental analysis for Senseonics Holdings Inc. yet.

Senseonics Holdings Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Senseonics Holdings Inc.

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a…

Full company profile